Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer.

Literature DB >> 24381143

Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer.

Mehmet Ali Nahit Sendur¹, Sercan Aksoy, Ozan Yazıcı, Nuriye Y Ozdemir, Nurullah Zengin, Kadri Altundag.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 24381143 DOI： 10.1007/s12032-013-0835-x

Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064

× No keyword cloud information.

13 in total

1. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.

Authors: Young Kwang Chae; Matias E Valsecchi; Jongoh Kim; Anabella Lucca Bianchi; Danai Khemasuwan; Ajit Desai; William Tester
Journal: Cancer Invest Date: 2011-09-21 Impact factor: 2.176

2. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Authors: Thomas P Ahern; Lars Pedersen; Maja Tarp; Deirdre P Cronin-Fenton; Jens Peter Garne; Rebecca A Silliman; Henrik Toft Sørensen; Timothy L Lash
Journal: J Natl Cancer Inst Date: 2011-08-02 Impact factor: 13.506

Review 3. Statins and cancer prevention.

Authors: Marie-France Demierre; Peter D R Higgins; Stephen B Gruber; Ernest Hawk; Scott M Lippman
Journal: Nat Rev Cancer Date: 2005-12 Impact factor: 60.716

4. Statin use and risk of breast cancer: a meta-analysis of observational studies.

Authors: Krishna Undela; Vallakatla Srikanth; Dipika Bansal
Journal: Breast Cancer Res Treat Date: 2012-07-18 Impact factor: 4.872

5. Statin use and breast cancer: prospective results from the Women's Health Initiative.

Authors: Jane A Cauley; Anne McTiernan; Rebecca J Rodabough; Andrea LaCroix; Douglas C Bauer; Karen L Margolis; Electra D Paskett; Mara Z Vitolins; Curt D Furberg; Rowan T Chlebowski
Journal: J Natl Cancer Inst Date: 2006-05-17 Impact factor: 13.506

6. Statins and cancer: a meta-analysis of case-control studies.

Authors: Marcia L Taylor; Brian J Wells; Michael J Smolak
Journal: Eur J Cancer Prev Date: 2008-06 Impact factor: 2.497

7. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.

Authors: Elisabeth R Garwood; Anjali S Kumar; Frederick L Baehner; Dan H Moore; Alfred Au; Nola Hylton; Chris I Flowers; Judy Garber; Beth-Ann Lesnikoski; E Shelley Hwang; Olofunmilao Olopade; Elisa Rush Port; Michael Campbell; Laura J Esserman
Journal: Breast Cancer Res Treat Date: 2010-01 Impact factor: 4.872

8. Statin use in primary inflammatory breast cancer: a cohort study.

Authors: T M Brewer; H Masuda; D D Liu; Y Shen; P Liu; T Iwamoto; K Kai; C M Barnett; W A Woodward; J M Reuben; P Yang; G N Hortobagyi; N T Ueno
Journal: Br J Cancer Date: 2013-07-02 Impact factor: 7.640

9. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Authors: B Mihaylova; J Emberson; L Blackwell; A Keech; J Simes; E H Barnes; M Voysey; A Gray; R Collins; C Baigent
Journal: Lancet Date: 2012-05-17 Impact factor: 79.321

Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer.

1. Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.

2. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Review 3. Statins and cancer prevention.

4. Statin use and risk of breast cancer: a meta-analysis of observational studies.

5. Statin use and breast cancer: prospective results from the Women's Health Initiative.

6. Statins and cancer: a meta-analysis of case-control studies.

7. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.

8. Statin use in primary inflammatory breast cancer: a cohort study.

9. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

10. Statin use and cancer risk in the General Practice Research Database.

1. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.

Review 2. Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?

3. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.

Review 4. Current and Emerging Uses of Statins in Clinical Therapeutics: A Review.